| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_83dffc287358331deccd774ddf93f551 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-318
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-9789
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00 |
| filingDate |
2019-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7714737c402851097d7dc5a82f8e34af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27c39a580fc0efed7ec9b1e7edfe9462
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_854ec6c7d19d41ca72a28b7dc2381fd8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9936ccfc11d95ce4c992ff6baaa6eedd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de8626755dfabe3462ec6444d3e1af6b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcc9b402b1bb5418149f9bdbf309371d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85db60076fc3a6a19d689f73da83e909 |
| publicationDate |
2021-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210006089-A |
| titleOfInvention |
Pharmaceutical composition for preventing or treating vitiligo or canities comprising extract of Mangifera indica L. extract as an active ingredient |
| abstract |
The present invention relates to a pharmaceutical composition for preventing or treating vitiligo or leukoplakia comprising an apple mango extract as an active ingredient, and the apple mango extract of the present invention has no cytotoxicity, as well as differentiation and migration of melanoblasts. As it promotes and exhibits antioxidant activity, it can be usefully used in the treatment of vitiligo or alopecia. |
| priorityDate |
2019-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |